Since the Canadian Securities Exchange (CSE) launched the CSE25 Index in 2017, cannabis stocks have continued to hold onto the top spots on the list.

The CSE25 is a subsection of the CSE Composite Index, and is made up of the 25 biggest stocks by market cap contained within that larger index. CSE25 companies make up more than 50 percent of the CSE Composite Index by weight, and are firms that tend to attract higher trading volumes.

Not all CSE25 companies are cannabis stocks (click here for the full list), but the five largest stocks within the index are focused on marijuana, and many others are as well. That’s because in contrast to other Canadian exchanges, the CSE has become the base for several US-based cannabis firms.

The strength of cannabis stocks on the CSE is a marker of the high interest in the sector, and the exchange gives investors a chance to get involved in the marijuana market to the south.

Here the Investing News Network takes a look at the five biggest CSE25 Index cannabis stocks. Their weightings on the index were current as of January 8, 2020, and companies are listed from largest to smallest weight on the index.

1. Curaleaf Holdings (CSE:CURA,OTCQX:CURLF)

Holding the top spot on the CSE25 is Massachusetts-based Curaleaf Holdings.

The US multi-state operator (MSO) currently has operations in key marijuana markets across the country, including Florida, Nevada and Oregon.

Recently, the firm has been making moves to widen its reach across the country as well as to further grow its presence in its existing markets.

Curaleaf started the year on a high note when it was awarded one of 14 medical cannabis retail licenses in Utah, giving it an early start in the state’s burgeoning market. The license follows Curaleaf’s acquisition of the retail assets of Nevada-based Acres Cannabis, one of which is a well-positioned dispensary on the Las Vegas strip.

Curaleaf currently boasts a 33.5 percent weight on the CSE25.

2. Green Thumb Industries (GTI) (CSE:GTII,OTCQX:GTBIF)

GTI takes second place with a weighting of 17.8 percent on the index.

The Illinois-based MSO is looking to cash in on the market in its home state with the recent legalization of adult-use cannabis in the region.

GTI announced the opening of Illinois’ first adult-use cannabis store, adding to its list of existing locations, and the midwestern state rang in the new year with its first sales of recreational marijuana.

In its Q3 2019 report, the company said it had Illinois and other key states to thank for its revenue generation, which reached US$68 million for the period, a quarter-over-quarter increase of 52 percent from the US$44.7 million seen in Q2 of last year.

3. Cresco Labs (CSE:CL,OTCQX:CRLBF)

Third place on the CSE25 is held by Cresco Labs, another Illinois native, with a weight of 6.6 percent.

Cresco has attracted investor attention for its series of acquisitions, particularly its takeover of Origin House (CSE:OH,OTCQX:ORHOF), which it called the “largest-ever public company acquisition” when it was first announced in April 2019.

Cresco confirmed the closing of the deal in early January, mentioning that the acquisition has increased its access to California, which is the world’s largest cannabis market, according to a report from Arcview Market Research and BDS Analytics.

“With the closing of this transaction, Cresco is in a position to accelerate its entry into one of the largest legal cannabis markets in the world, while adding valuable expertise in wholesale distribution and brand development, which we expect will drive significant value for all of our shareholders as we scale across the country in the coming years,” said CEO Charlie Bachtell in a statement.

4. Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF)

Perhaps Trulieve Cannabis’ biggest strength is its market dominance in its home state of Florida. The firm ended 2019 with the opening of its 42nd Florida location, maintaining its grip on the title of largest cannabis company in the coastal state.

In fact, in its Q3 2019 report, Trulieve reported a 19 percent increase in Florida patient growth and record revenue levels of US$70.7 million, a 22 percent increase on a quarter-over-quarter basis.

According to the most recent data from Florida’s Office of Medical Marijuana Use, Trulieve sold just under 28 million milligrams of medical cannabis in the week ended January 2, 2020. Privately held Surterra Wellness came in at a distant second, selling 8 million milligrams in the same time period.

Trulieve holds a 5.7 percent weighting on the CSE25.

5. Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF)

Rounding out the top five is Arizona-based Harvest Health & Recreation with a 4.4 percent weighting on the CSE25 Index.

Harvest spent a good deal of 2019 expanding its reach in Arizona with a series of acquisitions, including the takeover of medical cannabis operator Urban Greenhouse and the purchase of a Leaf Life medical cannabis dispensary in Southern Arizona.

The firm kicked off 2020 with news of a planned acquisition in another key marijuana state: Nevada.

Harvest plans to acquire a 32,000 square foot cultivation facility in Nevada from cannabis management platform MJardin Group for US$35 million.

“We expect this opportunistic acquisition to support our expanding retail asset base in Nevada and afford higher margins and profitability through vertical integration with some of our pending acquisitions in the state,” said Harvest CEO Steve White in a press release.

This is an updated version of an article originally published by the Investing News Network in 2018.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less